Drug Target Review2025-03-24T09:00:10
High-grade glioma, an aggressive brain cancer affecting both paediatric and adult patients, remains difficult to treat. A collaborative study from the University of Michigan, Dana-Farber Cancer Institute, and the Medical University of Vienna reveals a promising new treatment approach.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-06T07:26:00Z
Author Dr Tina Rogers
2026-11-05T10:04:00Z
2026-09-03T07:00:00
Contributor Marty Parrish and Steve Hoffmann, Drug Target Review
2026-03-25T15:00:00
Sponsored by Yokogawa
2025-05-14T14:30:00
Sponsored by Abzena
2023-07-04T10:05:58
Sponsored by Revvity
2026-09-18T15:56:00
Contributor Dr Garegin Papoian, Drug Target Review
2026-07-01T06:30:00
Sponsored by BPS Bioscience, Dr Veronique Baron
Site powered by Webvision Cloud